Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcf9d7dac3a69acf14ea77810bb74b25 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406 |
filingDate |
2019-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4bcfaffb7ba32a7e26d656ece7215c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f27fc47b68bc5bdf3dc5f86eea8319ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_435ade338920ca7c0279d12ae8e91968 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1806807bf2591d3c1a66b2ef994896f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9264c707e4dd248d4242f79d213e45e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_240febe43c739d3f00c04c080533b8df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b587fdf15ebad3b0f2c8b7a29e201ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a218a8da365fa84f0b3ba5b3bb55c00 |
publicationDate |
2021-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021315881-A1 |
titleOfInvention |
Combination of histone deacetylase inhibitor and protein kinase inhibitor and pharmaceutical use thereof |
abstract |
Use of a combination of a histone deacetylase inhibitor and a protein kinase inhibitor in the preparation of a medicament for the treatment or prevention of tumors, a pharmaceutical composition comprising a histone deacetylase inhibitor and a protein kinase inhibitor as active ingredients, and a method for treating or preventing cancers by combining a histone deacetylase inhibitor and a protein kinase inhibitor. |
priorityDate |
2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |